Does Exosome Therapy Work? What the Studies Show and Do Not Show

The evidence is preliminary. Early studies report short-term improvements in measures such as hydration, texture and wrinkle scores, but most are small and short, and many are not randomized.

None of the studies we cite shows that results last, and none replaces a conversation with a doctor.

Last reviewed October 15, 2026

The studies at a glance

Studies behind this site. Each was opened on October 15, 2026.
Study	Type	Size	What was measured	Limits
2024 review, PMID 38633728	Systematic review	9 studies of topical exosomes	Collagen deposition and overall appearance, among other outcomes	Included live-animal work; evidence level 3
2026 review, PMID 41756341	Systematic review	19 human studies	Hydration, elasticity, wrinkles, pores, pigmentation	Most not randomized; short follow-up; uneven methods
2026 review, PMID 42027180	Systematic review	8 studies, 3 to 60 participants each	Microneedling plus exosomes across several skin concerns	Some included studies were on other conditions; authors ask for more safety and effect data
2026 trial, PMID 42635327	Randomized split-face	60 adults	Wrinkle score at week 12, texture, pores, redness and more	Unblinded; 12 weeks; no tissue markers
2026 trial, PMID 42621380	Randomized comparison	100 participants with acne scars	Scar score at 3 months, laser alone vs laser plus a topical product	Product was exosome-mimetic nanovesicles plus polynucleotide, used with a laser

PubMed links are in the sources list at the bottom of this page.

What each kind of study can tell you

Systematic reviews gather many studies. They are only as good as the studies inside them, and here those studies are small and uneven.
Split-face trials treat one side of the face with the product and the other without it. They compare like with like within one person, but they are small and often not blinded.
Laboratory work shows what particles can do in cells or animals. It does not show what a product does on a person's face.

What these studies do not prove

That a product on a shelf matches the one studied. Reviews note that "exosome" is used loosely and that sources and methods vary. (PMID 42353255; the ISEV guidelines also discuss naming problems, PMID 38326288.)
That the exosome did the work. In the acne-scar trial above, a laser was used in both groups, and the topical product was exosome-mimetic nanovesicles plus polynucleotide, so the effect cannot be put down to exosomes alone.
That results last. Follow-up in these studies runs from weeks to a few months.
That it is safe for you. See the safety guide.

A closer look at one trial

Sixty adults took part in a randomized split-face trial. One side of the face had radiofrequency microneedling followed by a topical extracellular vesicle product. The other side had radiofrequency microneedling alone. At week 12 the wrinkle score had improved by 12.59 points on the product side and 9.28 on the other, a paired difference of 3.32 points (95% confidence interval 2.55 to 4.08). Texture, pores, redness, melanin, hydration and global assessments leaned the same way, and local reactions were mostly mild and passed.

The authors describe a short-term signal and call for caution, because the study was not blinded, followed people for 12 weeks and had no tissue or molecular markers. (PMID 42635327)

What the FDA has to say

The FDA said in 2019 that there are no FDA-approved exosome products. A study of a product is not an approval of it. See the FDA status guide.

Quick answers

Do exosomes work?

Early studies report short-term changes in skin measures, but most are small, short and not always randomized. The evidence is preliminary.

Is there long-term data?

None of the studies we cite has long-term data. The 2026 reviews of exosome studies call for longer follow-up.

Do exosome reviews on social media count as evidence?

Personal accounts are not controlled studies. They cannot tell you what would have happened without the product.

Sources

This page has not yet been reviewed by a licensed clinician. Sources are listed below. Last editorial check: October 15, 2026.